Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Using neurohormones to control keratin can lead to new skin disease treatments.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

TRH stimulates human hair growth and extends the hair growth phase.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Low ferritin levels are linked to increased hair loss; no link found between vitamin B12, TSH levels, and hair loss.

Caffeine may help reduce stress-induced hair loss.

Recombinant human growth hormone helps burn wounds heal faster by increasing blood vessel growth.

Five different TPO gene mutations were found in PCOS patients with thyroid hormone issues.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

People with alopecia areata often have abnormal thyroid hormones, thyroid antibodies, antinuclear antibodies, low vitamin D, and high C-reactive protein levels.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

The dog recovered from hypothyroidism and regrew its hair after two months of treatment.